Blister Pack Pharmaceutical Products Market: Introduction
Transparency Market Research delivers key insights on the blister pack pharmaceutical products market in its published report, which include global industry analysis, size, share, growth, trends, and forecast for 2020–2030. In terms of revenue, the global blister pack pharmaceutical products market is projected to expand at a CAGR of 6.7% during the forecast period, owing to several factors, about which TMR offers detailed insights and forecasts in the blister pack pharmaceutical products market report.
Pharmaceutical products such as tablets and capsules are generally pack and seal in variety of blister packaging formats. Blister packaging have brought about a significant change in the way pharmaceuticals tablets and capsules are packed, sealed, and shipped, especially on a large scale. The demand analysis of blister pack pharmaceutical products market is conducted as per drug type, manufacturing process, and end use. The TMR team witnessed that the tablets drug type segment is expected to outpace other segments in terms of market share during the forecast period.
Get Sample Copy:
High Preference for Unit Dosing and Small Pack Sizes Supports Sales
Unit dosing leads to higher protection of the primary product from being contaminated, as only the amount required for one time is taken out, while rest of the product remains sealed and secured from external contaminants. Thus, majority of consumers prefer unit dosing. The several benefits offered by unit dosing over bulk packed products have driven manufacturers offering pharmaceuticals products to adopt small pack sizes for their products. High investments in pharmaceuticals have boosted pharmaceutical packaging. The rapid adoption of such unit dosing and small sizing packaging formats, including blister packaging format in the pharmaceutical industry to prevent overconsumption of drugs, is boosting the blister pack pharmaceutical products market.
Inclusion of High-end Technologies Amplifying Sales of Blister Packaging Products in Pharmaceutical Industry
The global blister pack pharmaceutical products market is driven by innovation in product packaging, and consumer convenience is the epicenter. Leading packaging giants operating in the global blister pack pharmaceutical products are constantly incorporating advanced packaging technologies such as thermoforming and cold forming to pack and seal variety of pharmaceutical tablets and capsules, as it fulfils the precise packaging requirement. Furthermore, the demand for oral pharmaceuticals drugs has grown significantly over the past couple of years and projected to witness significant spike in upcoming years. The ability of thermoforming and cold forming packaging technologies to pack tablets and capsules at faster rate coupled with exceptional moisture, oxygen, and light barrier properties ultimately helps pharmaceutical companies to sell and distribute tablets and capsules on a large scale.
Incorporation of such packaging technologies in pharmaceutical packaging, including blister packaging, is anticipated to augment the sales of blister pack pharmaceutical products during the forecast period.
Availability of Alternative Packaging Solutions to Restrict Market Growth
Manufacturers in global blister pack pharmaceutical products market are eager to switch to advancements in packaging formats. Although, major portion of pharmaceuticals capsules and tablets is packed in the blister packaging format; there are adequate alternative packaging formats available in the market. Packaging format, such as bottles, jars, and containers are frequently used in the pharmaceutical industry to pack, seal, and store tablets and capsules. Furthermore, pharmaceutical companies sometimes prefer these packaging solutions to pack and seal tablets and capsules in bulk. The adequate availability of these alternative packaging solutions is considerably impacting the sale of blister pack pharmaceutical products. Development and adoption of such alternative packaging solutions in the pharmaceutical industry restrict the blister pack pharmaceutical products market growth to a certain extent.
Buy Complete [email protected]:
Blister Pack Pharmaceutical Products Market: Competition Landscape
The global blister pack pharmaceutical products market is projected to witness strong competition among key players. This market includes few well established market participants. Along with this, several other local and small scale manufacturers are also entering into blister pack pharmaceutical products market attributing to significant revenue creation with the rising demand for blister pack pharmaceutical products. Some of the key players operating in the global blister pack pharmaceutical products market are Pfizer Inc, GlaxoSmithKline plc, Sanofi, Sun Pharmaceutical Industries Ltd, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Cadila Healthcare, etc.
The tier structure is formulated on the basis of segmental revenue and market share of the company. As per tier structure, Pfizer Inc, Roche Holding AG, and Novartis AG are tier 1 players in the blister pack pharmaceutical products market. These leading companies are adopting key strategies such as business expansions, acquisitions, and product launch to strengthen their position in the blister pack pharmaceutical products market. Moreover, tier 2 players are GlaxoSmithKline plc, Johnson & Johnson, and Merck
Global Blister Pack Pharmaceutical Products Market Segmentation
Blister Pack Pharmaceutical Products Market by Drug Type
Blister Pack Pharmaceutical Products Market by Manufacturing Process
- Cold Forming
Blister Pack Pharmaceutical Products Market by End Use
- Nutraceuticals and Supplements
- Veterinary Drugs
Blister Pack Pharmaceutical Products Market by Region
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
Read Our Latest Press Release: